Development and simultaneous application of multiple care protocols in critical care: amulticenter feasibility study by Takala, Jukka et al.
Intensive Care Med (2008) 34:1401–1410
DOI 10.1007/s00134-008-1084-x O R I G I N A L
Jukka Takala
R. Philip Dellinger
Kati Koskinen
Arthur St. Andre
Martyn Read
Mitchell Levy
Stephan M. Jakob
Patricia Veiga C. Mello
Raymond Friolet
Esko Ruokonen
Development and simultaneous application
of multiple care protocols in critical care:
a multicenter feasibility study
Received: 21 September 2007
Accepted: 3 March 2008
Published online: 3 April 2008
© Springer-Verlag 2008
Electronic supplementary material
The online version of this article
(doi:10.1007/s00134-008-1084-x) contains
supplementary material, which is available
to authorized users.
Conflicts of interest: This trial was
investigator initiated and received funding
from TEKES (Finnish funding agency for
technology and innovation), and from Deio
(Helsinki, Finland) to cover part of the
research personnel costs and the costs of
data collection and statistical analysis. The
software prototype was written by Deio
based on specifications from the investi-
gators. Author K.K. is an employee of
Intensium (Kuopio, Finland), a company
that managed the data collection and
statistical analysis. No other conflicts of
interest are declared.
These authors performed this study on
behalf of the CPIC Study Group.
J. Takala () · S. M. Jakob · R. Friolet
Bern University Hospital and University of
Bern, Department of Intensive Care
Medicine,
Freiburgstrasse, 3010 Bern, Switzerland
e-mail: jukka.takala@insel.ch
Tel.: +41-31-6324144
Fax: +41-31-6324100
R. P. Dellinger
Cooper University Hospital, Critical Care
Division, Dorrance 393,
One Cooper Plaza, Camden,
NJ, 08103, USA
K. Koskinen
Intensium Ltd.,
Microkatu 1, 70211 Kuopio, Finland
A. St. Andre
Washington Hospital Center, Surgical
Critical Care, Rm 4B 42,
110 Irving Street NW,
Washington, DC, 20010, USA
M. Read
University Hospital of Wales, Critical Care
Services, Cardiff and Vale NHS Trust,
Heath Park, CF14 4XW Cardiff, UK
M. Levy
Rhode Island Hospital, Medical Intensive
Care Unit,
593 Eddy Street, Providence,
RI, 02906, USA
P. V. C. Mello
Universidade Estadual Piaui, Intensive Care
Unit, Hospital de Terapia Intensiva,
2131 Anfrisio Lobao Teresina, 64041-280
Piaui, Brazil
E. Ruokonen
Kuopio University Hospital, Department of
Intensive Care,
P.O. Box 1777, 70211 Kuopio, Finland
Abstract Objective: To test the
feasibility of and interactions among
three software-driven critical care
protocols. Design: Prospective
cohort study. Setting: Intensive care
units in six European and American
university hospitals. Patients: 174
cardiac surgery and 41 septic pa-
tients. Interventions: Application
of software-driven protocols for car-
diovascular management, sedation,
and weaning during the first 7 days
of intensive care. Measurements
and results: All protocols were
used simultaneously in 85% of the
cardiac surgery and 44% of the septic
patients, and any one of the protocols
was used for 73 and 44% of study
duration, respectively. Protocol use
was discontinued in 12% of patients
by the treating clinician and in 6% for
technical/administrative reasons. The
number of protocol steps per unit of
time was similar in the two diagnostic
groups (n.s. for all protocols). Initial
hemodynamic stability (a protocol
target) was achieved in 26 ± 18 min
(mean ± SD) in cardiac surgery and
in 24 ± 18 min in septic patients.
Sedation targets were reached in
2.4 ± 0.2 h in cardiac surgery and
in 3.6 ± 0.2 h in septic patients.
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Weaning protocol was started in 164
(94%; 154 extubated) cardiac surgery
and in 25 (60%; 9 extubated) septic
patients. The median (interquartile
range) time from starting weaning
to extubation (a protocol target) was
89 min (range 44–154 min) for the
cardiac surgery patients and 96 min
(range 56–205 min) for the septic
patients. Conclusions: Multiple
software-driven treatment proto-
cols can be simultaneously applied
with high acceptance and rapid
achievement of primary treatment
goals. Time to reach these primary
goals may provide a performance
indicator.
Keywords Cardiac surgery · Critical
care · Disease management · Seda-
tion · Treatment protocols · Weaning
Introduction
The increasing complexity of critical care processes and
the variety of available diagnostic, monitoring, and inter-
ventional technologies present a challenge for providing
the best possible care. Outside of health care, protocols
have been used routinely for decades in the control of
various complex processes in which safety, efficient
resource utilization, and constant quality of the product
have high priority. Typical examples include the aviation,
nuclear power, petrochemical, and paper industries [1].
Despite the well-recognized complexity of critical care,
systematic use of care protocols to control the delivery
of critical care remains uncommon. When used, these
protocols are rarely electronic. This is in sharp contrast
to the wide application of software-driven process control
outside of health care [1].
The potential for improving the quality of care by using
protocols has been demonstrated in several recent studies
in which single aspects of care delivery have been stan-
dardized. Such successes include sedation [2, 3], wean-
ing from mechanical ventilation [4, 5], lung-protective me-
chanical ventilation [6, 7], goal-directed therapy in early
sepsis [8] and in high-risk surgery [9, 10], and hemody-
namic management after cardiac surgery [11, 12].
The areas of care where protocols have been proven
useful are often closely interrelated; hence, software-
driven process control using multiple protocols simul-
taneously would conceptually make sense, and using
software to drive protocols at the bedside could facilitate
their clinical application. However, even the application of
single protocols in routine clinical practice outside clinical
trials is associated with problems in compliance, accep-
tance, multiplication and generalizability [13, 14]. Before
there can be any evaluation of potential benefits from the
simultaneous use of multiple protocols, the feasibility of
this concept in the clinical routine should be assessed.
The aim of this international, multicenter study was to
test in a clinical trial the feasibility and interactions among
three software-driven critical care protocols (cardiovascu-
lar management, sedation, and weaning). The potential ar-
eas of protocolized care were defined, the rates of events
triggering their use were assessed, and the protocols were
developed by the study participants.
Materials and methods
The study protocol was approved by the ethics commit-
tee or institutional review board of each of the participat-
ing centers. The study was conducted from late 2002 to
mid-2003. Written informed consent was obtained from
the cardiac surgical patients (in one center the need for in-
formed consent was waived). In septic patients, either the
need for informed consent was waived or deferred consent
was used.
Prior to the clinical study, potential protocol areas
were identified by centers and in expert meetings using
a modified Delphi process. The occurrence rate of clinical
protocol triggers was prospectively studied in six potential
areas (% of patients with triggering events shown; details
in ESM): cardiovascular management (88%); sedation
(67%); weaning (22%); source control of infection (78%);
coagulopathy (6%); and thrombocytopenia (5%). Three
protocols with frequent triggering events and rapid rates
of flow through the protocol (sedation, weaning, and
cardiovascular management) were developed using a mod-
ified Delphi process and tested in this prospective clinical
feasibility study. Eight centers (four from the U.S., four
from Europe) participated in the first two phases and six
centers (three from the U.S., three from Europe) in the
third phase. One center in Europe and one in the U.S. had
no cardiac surgery patients, whereas one center in the U.S.
had only cardiac surgery patients.
Baseline period
Severity of illness (SAPS II score without the Glasgow
Coma Scale component due to the potential for sedation
influence) and crude outcomes (length of stay, intensive
care unit and hospital outcome) were recorded for 4 weeks
before protocol use for all patients eligible for the proto-
cols. In addition, protocol-related outcome variables (time
without mechanical ventilation and time without ino-
tropes/vasopressors) were recorded. Thereafter, 2 weeks
were used to train the research staff in the use of the
protocols and software tools. In parallel, the study
outline, execution, and the protocols’ contents were ex-
plained to the medical and nursing staff. The research staff
1403
provided hands-on training in application of the protocol
software. This training took place before the intervention.
Intervention period
Over a 4-week period, the protocols were applied in
patients who fulfilled the inclusion criteria. Due to
availability, the computerized systems were used in
a maximum of four patients simultaneously in each unit
on a “first-come, first-served” basis. The path through the
protocols, the flow rate through the protocols (number
of protocol steps per unit of time as an indicator of the
rate at which interventions are applied to solve problems
in care processes), time spent in and re-entries into
protocols, and the occurrence rate and causes of leaving
protocolized care were assessed. Severity of illness, organ
failures, crude outcomes, and protocol-related outcomes
Fig. 1 Cardiovascular management protocol. The protocol consisted
of a passive observation part (grey flow chart symbols: no hemo-
dynamic problems, C1–C25–C26–C27–C1) and an active treatment
part (white flow chart symbols). Hypovolemia loop: C1–C3 to C6–
C9; hypervolemia loop: C1–C3 to C11; (high) afterload loop: C1 to
C12–C14; inotropes loop: C1 to C15–C19; vasopressors loop: C1 to
C21–C22. Physician interaction needed in defining targets and re-
evaluation interval (C2, C27), in defining volume challenge (C6, C8,
C9), in diagnostics (C20, C24), and in primary selection of the drug
or other specific intervention (C9, C11, C14, C19, C22). BP, blood
pressure; CO, cardiac output; iACE, angiotensin converting enzyme
inhibitor
(time without mechanical ventilation and time without
inotropes/vasopressors) were recorded.
The protocol software was used for the first 7 days. Af-
terward, continued protocol use in paper format was en-
couraged but not verified.
Control period
After a 2-week washout period, control data were collected
for 4 weeks for all patients eligible for the protocols, but
no protocols were used. Severity of illness, organ fail-
ures, crude outcomes, and protocol-related outcomes
(time without mechanical ventilation and time without
inotropes/vasopressors) were recorded.
For all periods, the length of stay and outcome
data were collected until 30 days, discharge, or death,
whichever occurred first.
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Software tools
A prototype computerized tool (Deio, Kuopio, Finland)
containing the protocols and the information needed to de-
fine therapeutic triggers, goals of therapy, and the flow of
the patient through the protocol was applied for patient
care at the bedside.
Protocol application
Each protocol (Figs. 1–3) included a passive observation
part and an active part consisting of several treatment
loops. The clinical problems requiring interventions and
the variables and clinical findings available to guide
treatment were defined, but the interpretation of a clin-
ical problem (e. g., hypovolemia, presence of pain),
specifics of the intervention (e. g., selection of vasoactive
or sedative drug), and therapeutic targets (e. g., blood
Fig. 2 Sedation protocol. The protocol consisted of a passive obser-
vation part (gray flow chart symbols: no need for sedation, S1–S23–
S1) and an active treatment part (white flow chart symbols). Anal-
gesia loop: S1–S4 to S13–S19; sedation loop: S1–S4 to S5–S19; re-
duction of sedatives/analgesics loop: S19–S22. Physician interaction
needed in setting the target and reassessment rate (S2, S20, S23), and
in selecting the drug and dose and prescribing an infusion (S8, S10,
S15, S17)
pressure, level of sedation) were defined by the clinician
in charge.
Inclusion criteria
Cardiac surgical patients
All patients undergoing either coronary artery bypass
surgery, valve surgery, or a combination of both were
included.
Septic patients
All patients with clinically evident sepsis on admission
or within the first 24 h in the ICU, including clinical
evidence of infection and at least two of the following
signs, were included: fever or hypothermia (> 38 or
< 36°C); tachycardia (> 90 beats/min); tachypnea [> 20
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Fig. 3 Weaning protocol. The
protocol consisted of a passive
observation part (gray flow chart
symbols: not ready for weaning,
W1–W2–W24–W25–W1) and
an active treatment part (white
flow chart symbols). Spontan-
eous breathing trial loop:
W1–W6 to W7–W13b; pressure
support loop: W1–W6 to
W14–W21–W13b. SBT,
spontaneous breathing trial;
PSV, pressure support venti-
lation; ATC, automatic tube
compensation. Physician
interaction needed in starting
(W2, W24, W25), in defining
the method (W6, W20), and in
extubation (W13a)
breaths/min or PaCO2 < 32 mmHg (< 4.3 kPa)]; or leu-
kocytosis/leukopenia (> 12,000 or < 4,000 cu/mm3).
Statistical analysis
Descriptive statistics were used to characterize the patient
groups and the use of protocols. All statistics refer to the
intention-to-treat population of patients treated using the
computerized tool for protocols. The use of protocols as
a percentage of time in the ICU was calculated for the time
eligible for study protocol usage, i. e., for the actual length
of stay, if less than 7 days, or as a percentage of the 7 days
eligible for the use of protocols, if the stay was longer. The
effect of center, geographic area (Europe vs. U.S.), and
patient group (sepsis vs. cardiac surgery), on the patient
1406
flow rate through the protocol was tested by evaluating dif-
ferences in the slope of the regression between time spent
in protocol and the number of protocol steps using the
general linear model. Normal distribution of the variables
was tested, and logarithmic transformations were per-
formed where necessary. The regression residual statistics
and interaction terms were calculated and tested. Non-
parametric tests were used for not normally distributed
variables. Proportions were compared using the chi-square
test. A p-value of less than 0.05 was considered as statis-
tically significant. All statistical analyses were performed
using SPSS for Windows software (version 12.01, SPSS,
Chicago, Ill.).
Results
No significant differences were observed between the
baseline, protocol, and control periods in age, severity of
illness, length of ICU stay, or hospital outcome (Table 1).
The protocol software tool was used to treat 174 car-
diac surgery and 41 septic patients (Fig. 4). The SAPS II
scores of cardiac surgery patients were higher and the
length of stays were longer in the U.S. centers than in
the European centers, and there was a center-continent
interaction for SAPS II p < 0.001, for length of stay
p = 0.004). No significant differences were observed in
the septic patients. (For center-specific data see ESM,
Table ES1.)
Protocol usage
Protocol software tool usage was analyzed from the be-
ginning of the active treatment part of the protocol. Most
patient time was spent in the active part of the protocol
(Table 2). At least one protocol was used for 73 and 62%
Table 1 Patient age, intensive care unit and hospital mortality, length of intensive care unit stay, and severity of illness in baseline, protocol,
and control periods
Patients Age ICU mortality Hospital ICU length SAPS II b,c
(n) (years) a (%) mortality (%) of stay (days) b
Sepsis
Baseline 42 62 (14) 42.9 51 3.0 (1.5–8.8) 41 (30–55)
Intervention 54 60 (17) 38.9 48 6.3 (1.8–12.1) 46 (33–58)
Control 31 59 (19) 25.8 32 4.4 (2.1–10.1) 43 (31–56)
Outcome baseline + control 35.6 42
Cardiac surgery
Baseline 198 65 (11) 2.0 3.5 0.9 (0.8–1.9) 28 (23–33)
Intervention 220 65 (11) 2.2 2.2 0.9 (0.8–1.6) 27 (22–32)
Control 208 65 (11) 1.4 2.9 0.9 (0.8–1.6) 26 (21–31)
Outcome baseline + control 1.7 3.2
Statistics: center-continent interaction for SAPS II (p = 0.000) and for length of stay (p = 0.004) in the cardiac surgery patients, no signif-
icant differences in septic patients; a Mean + SD; b Median (IQ range); c The SAPS II scores were calculated without the Glasgow Coma
Scale component
Fig. 4 Distribution of patients (n = 215) between the two groups
(white slices: cardiac surgery; gray slices: sepsis) and geographical
areas (Europe and U.S.), and their respective hospital mortalities
of the study duration in the cardiac surgery and septic pa-
tients, respectively. All three protocols were used in most
(> 90%) of the cardiac surgery patients, and all three si-
multaneously in 85% (Table 2).
The most common combination of active protocols in
the septic patients was cardiovascular management and se-
dation. The cardiovascular management protocol was used
in 83% of septic patients, the sedation protocol in 66%,
and the weaning protocol in 61%.
Flow rate through the protocols
The number of protocol steps per unit of time was similar
in the two patient groups (Fig. 5). Significant differences
between centers (p = 0.001) and continents (p < 0.001;
Europe vs. U.S.) were observed only for the weaning
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Table 2 Number of patients in the individual protocols and their different combinations
Cardiac surgery Sepsis
No. of Time in No. of Time in
patients (%) active part (%) patients (%) active part (%)
Cardiovascular management 168 (97) 74 34 (83) 55
Sedation 162 (93) 73 27 (66) 82
Weaning 164 (94) 83 25 (60) 84
Cardiovascular management + sedation 156 (90) 27 (66)
Cardiovascular management + weaning 159 (91) 21 (51)
Cardiovascular management + sedation + weaning 147 (85) 18 (44)
Sedation + weaning 148 (85) 20 (49)
protocol (for detailed statistics see ESM, Table ES2),
which contained two alternative strategies (pressure
support weaning or spontaneous breathing trials). This
was associated with a more frequent use of the pressure
support weaning loop (Fig. 3; details of loops in ESM) in
Europe (in 98% of patients) vs. the spontaneous breathing
trial in the U.S. (in 79% of patients). The pressure support
loop of the weaning protocol contained more steps than
the spontaneous breathing trial loop.
Use of protocol components and achievement of targets
In cardiac surgery patients, the hypovolemia loop (C1–C3
to C6–C9; Fig. 1) and tapering of vasoactive agents (C1
to C25–C26; Fig. 1) were by far the most commonly used
components of the cardiovascular protocol (Fig. 5). In
septic patients, the hypovolemia loop, the vasopressor loop
(C1 to C21–C22, Fig. 1), and tapering of vasoactive agents
were the most commonly used protocol components
(Fig. 6). For the cardiovascular management protocol, the
following mean target levels were observed: mean arterial
blood pressure at least 63 mmHg; urinary output more
than 56 ml/h; lower limit for cardiac index 2.1 l/min m–2;
CVP at least 11 mmHg; CVP not more than 16 mmHg;
PAOP at least 13 mmHg; PAOP not more than 18 mmHg;
and SvO2 at least 63%.
Most of the loops were entered and re-entered one to
three times (> 80% of the patients), except the tapering
of vasoactive agents loop, where 42% of the patients re-
quired four or more entries and re-entries (for details see
ESM, Fig. ES1). Hemodynamic stability was achieved in
26 ± 18 min (mean ± SD) in the cardiac surgery patients
and in 24 ± 18 min in the septic patients. The hemody-
namic targets were not reached in 9 (5%) cardiac surgery
patients and in 4 (12%) septic patients.
The sedation protocol was initiated in 93% of the car-
diac surgery patients and 66% of the septic patients. Se-
dation scores (Ramsay score or RASS score) were used to
set sedation targets and to monitor the depth of sedation,
whereas pain was assessed clinically. The target levels of
sedation were reached in 96% of the cardiac surgery pa-
Fig. 5 Flow rate through the protocols (protocol steps/h, mean + SD;
CVmanagement: cardiovascular management protocol). In addition,
median (interquartile range) is indicated under the x-axis for each
protocol. (Statistics: cardiac surgery vs. sepsis n. s. for all protocols)
Fig. 6 Flow through the loops of cardiovascular management proto-
col: percentage of patients entering the loops in each patient group
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tients and 93% of the septic patients. The time needed to
reach the targets was 2.4 ± 0.2 h (mean ± SD) for the car-
diac surgery patients and 3.6 ± 0.2 h for the septic patients.
For weaning, progressive reduction of pressure support
was used as the method of choice in 69% of patients; the
European centers used pressure support almost exclusively
(98%), whereas the U.S. centers predominantly used the
spontaneous breathing trial (78%). Weaning was started in
94% of the cardiac surgery patients and 60% of the septic
patients (Table 2), and 89 and 17%, respectively, were
extubated during the use of the software tool. The median
time from start of weaning to extubation was 89 min
(interquartile range 44–154 min) for the cardiac surgery
patients and 96 min (interquartile range 56–205 min) for
the septic patients. In cardiac surgery patients, the time
from start of weaning to extubation was shorter in the U.S.
centers (European median 101 min, interquartile range
49–161 vs. US: 65 min, 40–120 min, p = 0.036), whereas
time from admission to extubation was similar (European:
median 542 min, interquartile range 359–822 min; U.S.:
570 min, 311–744 min). Due to the small number of
weaned septic patients, no continent or center effects were
analyzed.
Five patients of those treated with the protocol software
tool needed to be reintubated after having been extubated:
one cardiac surgery patient in the U.S. and two in Europe,
and two septic patients in Europe. All these patients had
been weaned with the progressive reduction of pressure
support approach. Of those patients for whom the protocol
software tool was not available, five patients were reintu-
bated (3 of 46 cardiac surgery patients and 2 of 13 sep-
tic patients, all in Europe). The overall reintubation rates
before, during, and after protocol application were com-
parable (baseline 9 of 240 admissions, protocol 10 of 274
admissions, control 13 of 239 admissions).
Protocol re-entries
Re-entries after exit from the active part of the protocol
(Fig. 7) were most common in the cardiovascular manage-
ment protocol, where 52% of the cardiac surgery patients
and 71% of the septic patients re-entered the active part
of the protocol, compared with 12 and 48%, respectively,
in the sedation protocol and 23 and 40% in the weaning
protocol.
Protocol violations/premature discontinuations
The use of protocols was discontinued in 25 patients (12%)
because of early death (4 deaths, 3 died during active
protocolized treatment) or therapy limitation/withdrawal
(4 patients), or need for an unrelated diagnostic or thera-
peutic intervention (e. g., reoperation; 17 patients). In the
remaining 190 patients, protocol-driven care was applied
Fig. 7 Re-entries into the active part of the protocol (% of patients).
CVmanagement: cardiovascular management protocol
without violations in 155 patients (82%); protocol use
was discontinued in 12 patients (6%) for technical or
administrative reasons (software malfunction in 8 pa-
tients, patient transfer, or not specified in 4 patients); and
protocol use was discontinued in 23 patients (12%) due
to the treating clinician’s decision to deviate from the
protocol-driven care (in 14 cardiac surgery and 9 septic
patients). In 11 cases (47% of all protocol deviations due
to clinical decisions), the deviation was from the sedation
protocol and was due to either an anticipated short need
for sedation or start of infusion without first trying bolus
sedation.
Discussion
This international, multicenter study tested in a clinical
trial the feasibility and interactions among software-driven
protocols for cardiovascular management, sedation, and
weaning. This study demonstrated that a uniform thera-
peutic strategy could be formulated based on a defined
sequence of logical steps, translated to treatment proto-
cols, and then applied using software tools in the clinical
management of critically ill patients in an international,
multicenter setting. The use of specific interventions
and care process components, the flow rate through
the protocols, and perhaps most importantly, the time
needed to achieve clinically relevant targets, provides
core information for process analysis and performance
indicators.
Although no effects on either crude or protocol-related
outcomes were observed, the study was designed to assess
feasibility and was not powered for outcome with these
specific protocols. Accordingly, any conclusions regard-
ing the outcome effects of the treatment strategies used
in this study or regarding protocols in general should be
drawn with caution. Also, the specific protocols used in
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this study should go through further validation before be-
ing integrated into routine clinical practice. Nevertheless,
software-driven process control using multiple protocols
was feasible, and the rarity of deviations from the protocol-
driven care due to clinician disagreement suggests high ac-
ceptance.
The patient groups were selected to cover a broad range
of clinical problems, a large number of patients, and two
care processes with very different characteristics: rapid
turnover and low mortality (cardiac surgery) and long stay
and high mortality (sepsis). The selection of protocol areas
was based on their relevance for both patient groups, the
prospectively verified occurrence rate of triggering events,
and their close interaction in clinical practice.
The high compliance rate with multiple protocols was
comparable to rates reported when using only one proto-
col [5, 6]. The high acceptance is probably related to sev-
eral factors [14–16]:
1. Much effort was invested in reaching a consensus be-
tween the participating centers with regard to treatment
strategies.
2. Specific disorders were defined in broad enough terms
to allow clinical interpretation, and local preferences in
monitoring, choice of drugs, and method of weaning
were allowed.
3. The protocols were mostly nurse-driven but required
physician interaction in specified steps.
4. The protocols focused on defining physiologic de-
rangements rather than cut-off limits. We suggest that
using this qualitative–physiologic approach instead
of strict numeric therapeutic targets is advantageous,
since the numeric targets for individual patients can be
highly variable and depend on the underlying clinical
condition.
5. An intensive training period prior to the protocol appli-
cation and support in protocol use for the duration of
the study were provided by the research personnel.
6. All of the participating units were either closed units
run by intensive care specialists or had intensive care
specialist-driven co-management.
Each protocol contained steps for which the time in-
terval between interventions can vary. This has a poten-
tially major impact on the rate of the care process. We
found no differences between patient groups, centers, or
continents in the number of protocol steps per time, except
in weaning. The two alternative weaning strategies con-
tained different numbers of protocol steps, which invali-
dates the number of protocol steps per time as a process
indicator in weaning. Indeed, the preferential use of spon-
taneous breathing trials in the U.S. resulted in shorter times
from start of weaning to extubation, fewer protocol steps
per time, but similar times from admission to extubation as
in the European centers.
Initial cardiovascular stabilization could be achieved
rapidly in both patient groups. In contrast, several hours
were needed to reach target levels of sedation. Difficulties
in reaching target sedation levels despite protocols have
been reported by others [1, 2]. Once the criteria for start-
ing weaning were reached, patients were weaned and ex-
tubated very rapidly in both groups and substantially faster
in comparison with weaning times reported previously [3].
This may reflect a synergy between the three protocols.
The simultaneous use of protocols for cardiovascular
management, sedation, and weaning likely reduced the
between-center variation in the patient care process. The
strategies of sedation, weaning, and cardiovascular man-
agement may have relevant impact on common outcome
variables, such as length of ICU stay or duration of me-
chanical ventilation. Reducing the inherent heterogeneity
between centers by simultaneous use of multiple protocols
may therefore facilitate the evaluation of specific interven-
tions targeted to influence these patient outcomes, not only
at a single center as part of a performance improvement
process but at many centers participating in a clinical
research trial.
Care protocols can improve patient outcome only if
the interventions they include are beneficial. Our results
demonstrate that use of electronic protocols can facilitate
care process analysis. Process flow rates, success rates, and
time needed to reach clinically relevant targets can serve as
performance indicators. In addition, broad aspects of pa-
tient management can be standardized in an international
multicenter clinical research setting. No conclusions re-
garding the impact of improved process control on patient
outcomes can be made on the basis of this feasibility study.
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